- Home
- MRUS vs PBF Comparison
MRUS vs PBF Comparison
Compare MRUS & PBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- PBF
- Stock Information
- Founded
- MRUS 2003
- PBF 2008
- Country
- MRUS Netherlands
- PBF United States
- Employees
- MRUS 260
- PBF N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- PBF Integrated oil Companies
- Sector
- MRUS Health Care
- PBF Energy
- Exchange
- MRUS Nasdaq
- PBF Nasdaq
- Market Cap
- MRUS 4.1B
- PBF 3.1B
- IPO Year
- MRUS 2016
- PBF 2012
- Fundamental
- Price
- MRUS $53.11
- PBF $23.83
- Analyst Decision
- MRUS Strong Buy
- PBF Hold
- Analyst Count
- MRUS 12
- PBF 13
- Target Price
- MRUS $87.92
- PBF $24.25
- AVG Volume (30 Days)
- MRUS 2.0M
- PBF 3.4M
- Earning Date
- MRUS 07-31-2025
- PBF 07-31-2025
- Dividend Yield
- MRUS N/A
- PBF 4.61%
- EPS Growth
- MRUS N/A
- PBF N/A
- EPS
- MRUS N/A
- PBF N/A
- Revenue
- MRUS $54,732,000.00
- PBF $31,536,100,000.00
- Revenue This Year
- MRUS $75.57
- PBF N/A
- Revenue Next Year
- MRUS $31.84
- PBF $7.58
- P/E Ratio
- MRUS N/A
- PBF N/A
- Revenue Growth
- MRUS 42.77
- PBF N/A
- 52 Week Low
- MRUS $33.19
- PBF $13.62
- 52 Week High
- MRUS $62.98
- PBF $48.20
- Technical
- Relative Strength Index (RSI)
- MRUS 53.18
- PBF 65.40
- Support Level
- MRUS $52.41
- PBF $17.53
- Resistance Level
- MRUS $54.59
- PBF $24.96
- Average True Range (ATR)
- MRUS 2.15
- PBF 1.33
- MACD
- MRUS -0.77
- PBF 0.46
- Stochastic Oscillator
- MRUS 7.62
- PBF 84.79
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About PBF PBF Energy Inc.
PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.